ACNS2321

A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas

Status:

OPEN TO ACCRUAL

Trial Type:
Age Group:
Both
Phase:

II

NCT Number:
Contact:

DeNardo, Bradley